Zero-Click Contouring: Automatic OAR and LNL Contouring for Dosimetrists and Physicians
CLEVELAND, OH / ACCESSWIRE / December 5, 2023 / MIM Software Inc., a leading global provider of medical imaging software, announced U.S. Food and Drug Administration (FDA) clearance of its newest AI auto-contouring solution, Contour ProtégéAI+™.
New Zero-Click AI Auto-Contouring Solution Gives Cancer Treatment Planners More Time for Plan Evaluation
Unlike other auto-contouring tools, Contour ProtégéAI+ requires no clicks. Contouring of lymph node level and OAR structures starts automatically, and no manual intervention is required to launch. Results are exported directly to the TPS or MIM for review. This gives dosimetrists and physicians more time to create quality treatment plans for their patients.
“Cancer treatment planning teams should have as much time as possible to focus on developing precise, individualized treatment plans,” said Jay Obman, Product Manager at MIM Software Inc. “The MIM team is thrilled that zero-click auto-contouring of lymph node level and OAR structures with Contour ProtégéAI+ will save clinicians the time-consuming manual effort that comes with other auto-contouring tools.”
Learn more about Contour ProtégéAI+.
About MIM Software Inc.
MIM Software Inc. is a privately held company headquartered in Cleveland, OH, with international offices in Beijing, Chengdu, and Brussels.
MIM Software sells its products globally to imaging centers, hospitals, specialty clinics, research organizations, and pharmaceutical companies. The company’s products are used in over 3,500 centers worldwide.
MIM Software is committed to enhancing patient care by providing customer-centered and innovative imaging solutions in the fields of Radiation Oncology, Radiology, Nuclear Medicine, Theranostics, Interventional Radiology, and Urology.
Contact Information
Bill Carruthers
Product Marketing Manager
bcarruthers@mimsoftware.com
216-455-0610
Jim Janek
Director of Marketing
jjanek@mimsoftware.com
440-212-4455
Related Files
mim softare logo.png
contour-protegeai-plus_logo.png
SOURCE: MIM Software Inc.
View source version on accesswire.com:
https://www.accesswire.com/812891/mim-software-inc-announces-fda-clearance-of-contour-protgai
NEWTOWN, Pa., Dec. 22, 2024 /PRNewswire/ -- The law firm of Edelson Lechtzin LLP is…
Miami, Florida--(Newsfile Corp. - December 21, 2024) - Amid the vibrant backdrop of Art Basel…
Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…
MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…
TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…
Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…